Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.

類似資料

• A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
  著者:: Reeve, J, 等
  出版事項: (1986)
• Human parathyroid peptide treatment of vertebral osteoporosis.
  著者:: Reeve, J, 等
  出版事項: (1993)
• hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.
  著者:: Reeve, J, 等
  出版事項: (1991)
• Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosis.
  著者:: Tellez, M, 等
  出版事項: (1995)
• The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34)
  著者:: Hesp, R, 等
  出版事項: (1981)